Opus Genetics (IRD) Metrics: History & Chart

Opus Genetics, Inc.(IRD)

Biotechnology · Durham, NC

$4.40+0.02 (+0.52%)

Delayed quote: Oct 6, 2026, 2:20 PM EDT

About Opus Genetics, Inc.

Opus Genetics, Inc. is a clinical-stage biopharmaceutical company focused on ophthalmology. The company is dedicated to discovering and commercializing innovative therapies to address significant unmet medical needs in patients suffering from refractive and retinal eye disorders. Its portfolio includes Phentolamine Ophthalmic Solution, currently used to reverse pharmacologically induced mydriasis (pupil dilation). This solution is also advancing through Phase III clinical trials for the treatment of presbyopia and impaired vision in dim light or at night. A leading candidate in its retinal pipeline is APX3330, a small-molecule inhibitor targeting the reduction oxidation effector factor-1 protein. APX3330 has successfully completed Phase II clinical trials for diabetic retinopathy. Furthermore, Opus Genetics is developing APX2009 and APX2014, two preclinical product candidates also aimed at various retinal indications. Originally founded in 2018 as Ocuphire Pharma, Inc., the company maintains its headquarters in Farmington Hills, Michigan.

Durham, NC

28 employees

opusgtx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: George Magrath

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	-13.27%
30D Total Return	-6.21%
YTD Total Return	+117.91%
1Y Total Return	+132.98%
3Y Total Return	N/A
5Y Total Return	N/A
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	+117.91%
2025	+68.91%
2024	N/A
2023	N/A
2022	N/A
2021	N/A

CAGR TTM	+132.04%
CAGR 3Y	N/A
CAGR 5Y	N/A
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

IRD Valuation Metrics

IRD Stock Price Metrics

IRD Dividend Metrics

IRD Growth Rate Metrics

IRD Discounted Cash Flow Metrics

IRD Returns By Period

IRD Yearly Returns

IRD Average Annual Returns By Period (CAGR)

IRD Revenue Metrics

IRD PE Ratio Metrics

IRD PS Ratio Metrics

IRD PB Ratio Metrics

IRD Price to Free Cash Flow Ratio Metrics

IRD Debt to Equity Ratio Metrics

IRD PEG Ratio Metrics

IRD FCF Yield

IRD Earnings Yield

IRD EBITDA Yield

IRD OCF Yield

IRD EV/EBIT Ratio Metrics

IRD EV/EBITDA Ratio Metrics

IRD EV/Assets Ratio Metrics

IRD EV/Sales Ratio Metrics

IRD Current Ratio Metrics

IRD Quick Ratio Metrics

IRD ROIC Metrics

IRD Return on Assets Metrics

IRD Return on Equity Metrics

IRD Net Profit Margin Metrics

IRD Gross Profit Margin Metrics

IRD Tax Rate Metrics

PS Ratio	49.50
PS Ratio Avg TTM	117.36
PS Ratio Avg 3Y	10.36
Current VS TTM Avg	-57.82%
Current VS 3Y Avg	+377.57%
Current VS 5Y Avg	+377.57%

PB Ratio	210.00
PB Ratio Avg TTM	16.31
PB Ratio Avg 3Y	9.82
Current VS TTM Avg	+1187.84%
Current VS 3Y Avg	+2039.41%
Current VS 5Y Avg	+2039.41%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	(2.69)
Debt/Equity Ratio Avg TTM	(0.60)
Debt/Equity Ratio Avg 3Y	0.00
Current VS TTM Avg	-345.43%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	4.67
Ev/Assets Ratio Avg TTM	24.68
Ev/Assets Ratio Avg 3Y	21.26
Current VS TTM Avg	-81.08%
Current VS 3Y Avg	-78.03%
Current VS 5Y Avg	-78.03%

Ev/Sales Ratio	44.03
Ev/Sales Ratio Avg TTM	114.38
Ev/Sales Ratio Avg 3Y	98.11
Current VS TTM Avg	-61.51%
Current VS 3Y Avg	-55.12%
Current VS 5Y Avg	-55.12%

Current Ratio	12.19
Current Ratio Avg TTM	5.78
Current Ratio Avg 3Y	7.32
Current VS TTM Avg	+110.96%
Current VS 3Y Avg	+66.56%
Current VS 5Y Avg	+54.23%

Quick Ratio	12.19
Quick Ratio Avg TTM	5.78
Quick Ratio Avg 3Y	7.32
Current VS TTM Avg	+110.96%
Current VS 3Y Avg	+66.56%
Current VS 5Y Avg	+54.23%

ROIC	(59.29%)
ROIC Avg 3Y	(96.16%)
ROIC Avg 5Y	(82.47%)
Current VS 3Y Avg	+38.35%
Current VS 5Y Avg	+28.11%
Current VS 10Y Avg	+42.90%

ROA	(115.75%)
ROA Avg TTM	(41.45%)
ROA Avg 3Y	(16.89%)
Current VS TTM Avg	-179.28%
Current VS 3Y Avg	-585.21%
Current VS 5Y Avg	-478.60%

ROE	N/A
ROE Avg TTM	(504.08%)
ROE Avg 3Y	(134.56%)
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Net Profit Margin	(1091.82%)
Net Profit Margin Avg TTM	(1072.53%)
Net Profit Margin Avg 3Y	(417.40%)
Current VS TTM Avg	-1.80%
Current VS 3Y Avg	-161.57%
Current VS 5Y Avg	-238.97%

Gross Profit Margin	99.87%
Gross Pft Margin Avg TTM	58.09%
Gross Pft Margin Avg 3Y	99.94%
Current VS TTM Avg	+71.93%
Current VS 3Y Avg	-0.07%
Current VS 5Y Avg	+71.00%

Tax Rate	0.25%
Tax Rate Avg 3Y	0.59%
Tax Rate Avg 5Y	0.59%
Current VS 3Y Avg	-57.10%
Current VS 5Y Avg	-57.10%
Current VS 10Y Avg	-57.10%